Drug slashes risk of death for women with high-risk breast cancer by 32
The drug, which is taken as a pill, has already been approved in the US and is currently being assessed for use in the UK and on the NHS.
Stay updated with breaking news from Simon Vincent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug, which is taken as a pill, has already been approved in the US and is currently being assessed for use in the UK and on the NHS.
A team of UK and US researchers studied 2,000 women with BRCA1 and BRCA2 early-stage cancer and gave half of them tablets of olaparib twice a day for a year.
Researchers say the findings are a key step forward in the fight against multiple types of cancer.
Researchers say the findings are a key step forward in the fight against multiple types of cancer.
It would be better to rule hundreds of thousands of women out of screening because they are at such low risk of the disease, according to Professor Fiona Gilbert.